These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10936061)

  • 1. The interferons and cell death: guardians of the cell or accomplices of apoptosis?
    Barber GN
    Semin Cancer Biol; 2000 Apr; 10(2):103-11. PubMed ID: 10936061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons, interferon-like cytokines, and their receptors.
    Pestka S; Krause CD; Walter MR
    Immunol Rev; 2004 Dec; 202():8-32. PubMed ID: 15546383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human interferons: structure and function.
    Zoon KC
    Interferon; 1987; 9():1-12. PubMed ID: 2445691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of interferon mediated anti-viral resistance.
    Clarke CJ; Trapani JA; Johnstone RW
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):117-30. PubMed ID: 12476793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the evolution of IFNs: zebrafish group II IFNs induce a rapid and transient expression of IFN-dependent genes and display powerful antiviral activities.
    López-Muñoz A; Roca FJ; Meseguer J; Mulero V
    J Immunol; 2009 Mar; 182(6):3440-9. PubMed ID: 19265122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferons--biologic principles and clinical uses].
    Jacobsen H; Kirchner H
    Klin Padiatr; 1985; 197(4):263-7. PubMed ID: 3930830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1.
    Bauvois B; Nguyen J; Tang R; Billard C; Kolb JP
    Biochem Pharmacol; 2009 Sep; 78(5):514-22. PubMed ID: 19433065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
    J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses.
    Lau JF; Horvath CM
    Mt Sinai J Med; 2002 May; 69(3):156-68. PubMed ID: 12035075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic effects of interferons: relevance to multiple sclerosis.
    Rudick RA; Ransohoff RM
    Mult Scler; 1995; 1 Suppl 1():S12-6. PubMed ID: 9345391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon: cellular executioner or white knight?
    Maher SG; Romero-Weaver AL; Scarzello AJ; Gamero AM
    Curr Med Chem; 2007; 14(12):1279-89. PubMed ID: 17504213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trophoblastic interferon-gamma: current knowledge and possible role(s) in early pig pregnancy.
    Cencic A; La Bonnardière C
    Vet Res; 2002; 33(2):139-57. PubMed ID: 11944804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.
    Paulus C; Krauss S; Nevels M
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3840-5. PubMed ID: 16497831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative signaling pathways regulating type I interferon-induced apoptosis.
    Pokrovskaja K; Panaretakis T; Grandér D
    J Interferon Cytokine Res; 2005 Dec; 25(12):799-810. PubMed ID: 16375608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between interferon and other cytokine systems in bone metabolism.
    Takayanagi H; Sato K; Takaoka A; Taniguchi T
    Immunol Rev; 2005 Dec; 208():181-93. PubMed ID: 16313349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma: an overview of signals, mechanisms and functions.
    Schroder K; Hertzog PJ; Ravasi T; Hume DA
    J Leukoc Biol; 2004 Feb; 75(2):163-89. PubMed ID: 14525967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.